APA

Zhou J., Wu R., High A. A., Slaughter C. A., Finkelstein D., Rehg J. E., Redecke V. & Häcker H. (20120109). A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Zhou Jingran, Wu Ruiqiong, High Anthony A, Slaughter Clive A, Finkelstein David, Rehg Jerold E, Redecke Vanessa and Häcker Hans. 20120109. A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Zhou J., Wu R., High A. A., Slaughter C. A., Finkelstein D., Rehg J. E., Redecke V. and Häcker H. (20120109). A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Zhou Jingran, Wu Ruiqiong, High Anthony A, Slaughter Clive A, Finkelstein David, Rehg Jerold E, Redecke Vanessa and Häcker Hans. A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease. : Proceedings of the National Academy of Sciences of the United States of America. 20120109.